Colorectal Cancer Trial, Recruiting NCT03748485 Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT03748485
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who, before surgery, were assessed as having stage III colorectal cancer (cancer that has spread to nearby lymph nodes but not to distant organs)
  • People whose colorectal cancer was confirmed as a specific type called adenocarcinoma through a biopsy taken during a colonoscopy or endoscopy
  • People whose tissue examined after surgery showed that the cancer was at a lower stage (T0–T3, no lymph node involvement, no spread) and did not have high-risk features suggesting the cancer might come back
  • People who are able to understand and sign a written consent form agreeing to take part

Who may not be able to join:

  • People who have a history of another type of cancer
  • People who needed emergency surgery due to a serious complication such as a bowel blockage, severe bleeding, or an abscess
  • People whose colorectal tumour had grown into the abdominal wall or nearby organs in a way that made complete surgical removal difficult
  • People with lymph node spread that could not be surgically removed
  • People rated as having poor physical fitness for surgery based on standard medical scoring tools used by anaesthetists and oncologists (confirm with trial site)
  • People with a physical or psychological dependence (confirm with trial site)
  • Women who are pregnant or breastfeeding
  • People with an infection that was not controlled before surgery
  • People who have taken part in another clinical trial within the past 4 weeks
  • People with other medical or test result findings that the trial investigators consider unsuitable (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jun Huang, MD/PHD, sixth affiliate hospital of Sun yatsen Hospital

Phone: +86 13808874808

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
Registry
ClinicalTrials.gov
Start date
30 April 2019
Est. completion
30 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

disease free survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov